SMC recommends combination metastatic bladder cancer therapy following strong clinical trial outcomes
Scottish medicines consortium (SMC) is recommending the reimbursement of PADCEV™ (enfortumab vedotin) with KEYTRUDA® (pembrolizumab) for the first-line treatment of adult patients with unresectable or metastatic urothelial cancer, who are eligible for platinum-containing chemotherapy.1,2 Bladder cancer is […]
NHS changes guidelines for bladder cancer patients following breakthrough research
Hundreds of people with advanced bladder cancer across the UK can now receive three rather than six chemotherapy cycles after research involving Sheffield Teaching Hospitals NHS Foundation and the University of Sheffield led to a change to NHS treatment guidelines. […]
Bladder cancer may be caused by the body’s response to a common virus, research suggests
Bladder cancer might be caused by our cell’s response to a common virus which infects nearly everyone in childhood, according to new research led by scientists at the University of […]
Bladder Oncology Study Day
Overview This multidisciplinary educational event brings together renowned experts and healthcare professionals to explore the rapidly evolving landscape of bladder cancer management. As one of the most common urological malignancies, […]
8th Bladder Cancer Translational Research Meeting
The Bladder Cancer Research Centre (University of Birmingham) and the Transforming cancer OUtcomes through Research (TOUR) team (King’s College London and Guy’s Hospital) are organising their 8th Bladder Cancer Translational […]
Bladder Oncology Study Day
Overview This multidisciplinary educational event brings together renowned experts and healthcare professionals to explore the rapidly evolving landscape of bladder cancer management. As one of the most common urological malignancies, […]
Sheffield bladder cancer patient praises cutting-edge trial
A man with bladder cancer who had a cutting-edge immunotherapy drug injected straight into his tumour is praising a groundbreaking trial which could help future patients avoid bladder removal surgery. […]
New discovery opens doors for early detection of aggressive early-stage bladder cancer
A new scientific study has identified a new molecular biomarker that could help doctors detect aggressive early-stage bladder cancer, such as high-grade non-muscle invasive bladder cancer (NMIBC), in both humans […]
Bladder cancer treatment doubling survival approved after Barts trial
A new treatment for bladder cancer, proven to double survival rates for people whose cancer has spread or cannot be removed by surgery, is now available on the NHS, offering […]
Don’t miss free international urologic cancer summit with world-leading experts
Leading experts in urology cancer from around the world are set to descend on the UK next month for a major summit. The International Urology Cancer Summit (IUCS) 2025 is […]
